NCT05188586View on ClinicalTrials.gov

New Onset Diabetes Management for Earlier Detection of Pancreatic Cancer (NODMED)

NATerminatedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

October 31, 2022

Primary Completion Date

March 16, 2023

Study Completion Date

March 16, 2023

Conditions
Pancreatic Cancer
Interventions
OTHER

MRI/Imaging

Blood collection and pancreatic cancer early detection testing with return of results.

Trial Locations (5)

85260-6411

Headlands Research - Scottsdale - PPDS, Scottsdale

33462-6631

JEM Research Institute - Headlands - PPDS, Atlantis

29605-4289

Prisma Health/Endocrinology specialist and Thyroid, Greenville

78231-1281

Consano Clinical Research, LLC, Shavano Park

20110-4421

Manassas Clinical Research Center, Manassas

Sponsors

Lead Sponsor

ClearNote Health
All Listed Sponsors
lead

ClearNote Health

INDUSTRY

NCT05188586 - New Onset Diabetes Management for Earlier Detection of Pancreatic Cancer (NODMED) | Biotech Hunter | Biotech Hunter